Cargando…
The utility of delayed-enhancement and t2-weighted cardiovascular mri for predicting clinical outcomes in patients at high risk for cardiac sarcoidosis
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106763/ http://dx.doi.org/10.1186/1532-429X-13-S1-O105 |
| _version_ | 1782205144809603072 |
|---|---|
| author | Vorasettakarnkij, Yongkasem Medina, Hector M Ahmed, Waleed Holmvang, Godtfred Deeprasertkul, Peerawut Verdini, Daniel J Uthamalingam, Shanmugam Brady, Thomas J Ghoshhajra, Brian B Sosnovik, David E |
| author_facet | Vorasettakarnkij, Yongkasem Medina, Hector M Ahmed, Waleed Holmvang, Godtfred Deeprasertkul, Peerawut Verdini, Daniel J Uthamalingam, Shanmugam Brady, Thomas J Ghoshhajra, Brian B Sosnovik, David E |
| author_sort | Vorasettakarnkij, Yongkasem |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3106763 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31067632011-06-03 The utility of delayed-enhancement and t2-weighted cardiovascular mri for predicting clinical outcomes in patients at high risk for cardiac sarcoidosis Vorasettakarnkij, Yongkasem Medina, Hector M Ahmed, Waleed Holmvang, Godtfred Deeprasertkul, Peerawut Verdini, Daniel J Uthamalingam, Shanmugam Brady, Thomas J Ghoshhajra, Brian B Sosnovik, David E J Cardiovasc Magn Reson Oral Presentation BioMed Central 2011-02-02 /pmc/articles/PMC3106763/ http://dx.doi.org/10.1186/1532-429X-13-S1-O105 Text en Copyright ©2011 Vorasettakarnkij et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Oral Presentation Vorasettakarnkij, Yongkasem Medina, Hector M Ahmed, Waleed Holmvang, Godtfred Deeprasertkul, Peerawut Verdini, Daniel J Uthamalingam, Shanmugam Brady, Thomas J Ghoshhajra, Brian B Sosnovik, David E The utility of delayed-enhancement and t2-weighted cardiovascular mri for predicting clinical outcomes in patients at high risk for cardiac sarcoidosis |
| title | The utility of delayed-enhancement and t2-weighted cardiovascular mri for predicting clinical outcomes in patients at high risk for cardiac sarcoidosis |
| title_full | The utility of delayed-enhancement and t2-weighted cardiovascular mri for predicting clinical outcomes in patients at high risk for cardiac sarcoidosis |
| title_fullStr | The utility of delayed-enhancement and t2-weighted cardiovascular mri for predicting clinical outcomes in patients at high risk for cardiac sarcoidosis |
| title_full_unstemmed | The utility of delayed-enhancement and t2-weighted cardiovascular mri for predicting clinical outcomes in patients at high risk for cardiac sarcoidosis |
| title_short | The utility of delayed-enhancement and t2-weighted cardiovascular mri for predicting clinical outcomes in patients at high risk for cardiac sarcoidosis |
| title_sort | utility of delayed-enhancement and t2-weighted cardiovascular mri for predicting clinical outcomes in patients at high risk for cardiac sarcoidosis |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106763/ http://dx.doi.org/10.1186/1532-429X-13-S1-O105 |
| work_keys_str_mv | AT vorasettakarnkijyongkasem theutilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT medinahectorm theutilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT ahmedwaleed theutilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT holmvanggodtfred theutilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT deeprasertkulpeerawut theutilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT verdinidanielj theutilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT uthamalingamshanmugam theutilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT bradythomasj theutilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT ghoshhajrabrianb theutilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT sosnovikdavide theutilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT vorasettakarnkijyongkasem utilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT medinahectorm utilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT ahmedwaleed utilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT holmvanggodtfred utilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT deeprasertkulpeerawut utilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT verdinidanielj utilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT uthamalingamshanmugam utilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT bradythomasj utilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT ghoshhajrabrianb utilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis AT sosnovikdavide utilityofdelayedenhancementandt2weightedcardiovascularmriforpredictingclinicaloutcomesinpatientsathighriskforcardiacsarcoidosis |